 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cantor Fitzgerald restated their overweight rating on shares of Elutia (NASDAQ:ELUT  Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. Cantor Fitzgerald...

Elutia (NASDAQ:ELUT) Receives "Overweight" Rating from Cantor Fitzgerald

SILVER SPRING, Md., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ( Elutia ), a company pioneering drug-eluting biomatrix products, today announced that Dr. Randy Mills, President...

Elutia to Participate in a Panel Discussion at the Cantor Global Healthcare Conference

Cantor Fitzgerald restated their overweight rating on shares of Elutia (NASDAQ:ELUT  Free Report) in a research note issued to investors on Tuesday, Benzinga reports. They currently have a...

Elutia (NASDAQ:ELUT) Earns Overweight Rating from Cantor Fitzgerald

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Elutia announces private placement with proceeds up to $26M

Elutia divests Orthobiologics business unit to Berkeley Biologics for $35M

Transaction Reflects Increasing Strategic Focus on Proprietary Drug-Eluting Biomatrix Platform SILVER SPRING, Md., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ( Elutia ), a...

Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million

SILVER SPRING, Md., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ( Elutia ), a company pioneering drug-eluting biomatrix products, today announced that Dr. Randy Mills, President...

Elutia to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Elutia, Inc. operates as a biotechnology company. It develops biologic products to improve compatibility between medical devices and the patients who need them. The firm operates through the following segments: Device Protection, Women’s Health, Orthobiologics and Cardiovascular. The Device Protection segment includes biological envelope that remodels into systematically connected, vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic vehicles. The Women’s Health segment includes pre-hydrated, human acellular dermal matrix, or HADM, that is designed to enable rapid integration, cellular repopulation and rapid revascularization at the surgical site. The Orthobiologics segment includes a variety of viable matrices, produced with a proprietary process that is designed to protect and preserve native bone cells and reduce programmable cell death, for use in bone repair and fusion procedures. The Cardiovascular segment includes a portfolio of extracellular matrices that retain the natural composition of collagen, growth factors and proteins for use in vascular and cardiac repair and pericardial closure. The company was founded by Kevin L. Rakin and Charles Randal Mills on August 6, 2015 and is headquartered in Silver Spring, MD.

Watchers	719
52-Wk Low	$1.10
52-Wk High	$9.01

Market Cap	$23.24M
Volume (M)	58,349.00
52-Wk High	$9.01
52-Wk Low	$1.10

ELUT Elutia Inc - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals